CVS Health Reported Another Stellar Quarter Despite Busy Acquisitions, but Disappointed by Guidance
CVS Health (CVS) stock is retreating more than 1.5% in premarket trading, being mostly affected by uncertainties over Fed’s rate decision tonight, rather than its freshly published quarterly results showing total revenues of $85.28 billion posted an 11% annual increase over the $76.83 billion.
May 3, 2023